$6M Takeda Verdict Reinstated In 1st Actos Cancer Trial
A California state appeals court on Thursday reinstated a $6.5 million jury award against Japan's Takeda Pharmaceutical Co. Ltd. in the first product liability trial over claims its diabetes drug Actos caused...To view the full article, register now.
Already a subscriber? Click here to view full article